Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled randomized Phase II trial of Elafin after major esophageal surgery
2008-000938-49Phase 2Completed
- Sponsor
- Proteo Biotech AG
- Start
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in Systemic Inflammatory Response Syndrome (SIRS) comparing Elafin treatment arm with Placebo arm (2 arms). Started Jan 2009; status: completed.
02
Drugs
tiprelestat
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on 2008-000938-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000938-49.